Eravacycline

Caitlin Soto, PharmD, BCIDP, Kathryn Dzintars, Pharm.D., BCPS

INDICATIONS

FDA

  • Treatment of complicated intra-abdominal infections (cIAI) caused by susceptible organisms in adults aged 18 years or older.
    • Limitation: Not indicated for complicated urinary tract infections.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: September 6, 2026